rs727503824
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_004183.4(BEST1):c.851A>G(p.Tyr284Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y284H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004183.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant vitreoretinochoroidopathyInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- inherited retinal dystrophyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- retinitis pigmentosaInheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- vitelliform macular dystrophy 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- autosomal recessive bestrophinopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- retinitis pigmentosa 50Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- adult-onset foveomacular vitelliform dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- MRCS syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- nanophthalmiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35754583, 33090715, 21109774, 35973442, 32207364) -
- -
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 284 of the BEST1 protein (p.Tyr284Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant BEST1-related conditions (PMID: 21109774, 32207364; internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 166746). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt BEST1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Vitelliform macular dystrophy 2 Pathogenic:1
- -
BEST1-related disorder Pathogenic:1
The BEST1 c.851A>G variant is predicted to result in the amino acid substitution p.Tyr284Cys. This variant has been reported in the heterozygous state in individuals with BEST1-related disease (Table S4, Liu et al. 2020. PubMed ID: 33090715; Garza-Garza et al. 2020. PubMed ID: 32207364; Hoyek et al. 2022. PubMed ID: 35754583; Supplementary Table 1 Wang et al. 2022. PubMed ID: 35973442; zygosity unknown in Cohn et al. 2010. PubMed ID: 21109774). In two families, this variant was inherited from affected or mildly affected parents, suggesting variable expressivity and/or incomplete penetrance, and also identified in an affected sibling (Garza-Garza et al. 2020. PubMed ID: 32207364; Hoyek et al. 2022. PubMed ID: 35754583). This variant is interpreted as likely pathogenic or pathogenic by multiple submitters in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/166746/). This variant has not been reported in a large population database, indicating it is rare. This variant is interpreted as likely pathogenic. -
Stargardt disease Pathogenic:1
Variant not found in gnomAD. Same amino acid change previously reported pathogenic (ClinVar: VCV000813024.1, predicted deleterious by in-silico pathogenicity predictors. (ACMG: PS2 Strong; PM2 Moderate; PP3 Supporting) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at